We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
-1.54%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$96.4B
AUM Growth
-$1.4B
(-1.4%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
33.93%
Holding
280
New
10
Increased
138
Reduced
66
Closed
10
Avg Time Held
2.2
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$363M |
| 2 |
JPMorgan Chase
JPM
|
+$363M |
| 3 |
American Airlines Group
AAL
|
+$310M |
| 4 |
CarMax
KMX
|
+$258M |
| 5 |
FedEx
FDX
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$779M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
+$394M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$213M |
| 4 |
Bath & Body Works
BBWI
|
+$134M |
| 5 |
GSK
GSK
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.64% |
| 2 | Healthcare | 23.8% |
| 3 | Industrials | 15.3% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Financials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Amgen
AMGN
$235B
| $4.38B | 4.54% |
29,181,826
+4,600
| +0% | +$683K |
2013 Q2
11 quarters
|
|
2
Biogen
BIIB
$34.8B
| $4.23B | 4.39% |
16,246,726
+436,101
| +3% | +$115M |
2013 Q2
11 quarters
|
|
3
Eli Lilly
LLY
$1.12T
| $4.16B | 4.31% |
57,756,918
+102,526
| +0.2% | +$7.76M |
2013 Q2
11 quarters
|
|
4
Southwest Airlines
LUV
$20B
| $3.32B | 3.45% |
74,206,258
+117,900
| +0.2% | +$4.8M |
2013 Q2
11 quarters
|
|
5
Microsoft
MSFT
$4.01T
| $3.29B | 3.41% |
59,535,523
+99,930
| +0.2% | +$5.24M |
2013 Q2
11 quarters
|
|
6
Texas Instruments
TXN
$255B
| $3.13B | 3.25% |
54,529,986
+46,050
| +0.1% | +$2.44M |
2013 Q2
11 quarters
|
|
7
Adobe
ADBE
$97.9B
| $3.12B | 3.23% |
33,213,085
-31,025
| -0.1% | -$2.69M |
2013 Q2
11 quarters
|
|
|
8
FedEx
FDX
$69.9B
| $2.62B | 2.72% |
16,116,764
+1,371,175
| +9% | +$191M |
2013 Q2
11 quarters
|
|
9
Alphabet (Google) Class A
GOOGL
$4.27T
| $1.97B | 2.04% |
51,625,320
+72,540
| +0.1% | +$2.67M |
2015 Q3
2 quarters
|
|
10
Alphabet (Google) Class C
GOOG
$4.22T
| $1.88B | 1.95% |
50,364,540
-19,240
| -0% | -$689K |
2013 Q2
11 quarters
|
|
11
Charles Schwab
SCHW
$163B
| $1.56B | 1.62% |
55,743,131
+54,700
| +0.1% | +$1.44M |
2013 Q2
11 quarters
|
|
|
12
Bath & Body Works
BBWI
$4.12B
| $1.56B | 1.61% |
21,927,706
-1,862,551
| -8% | -$134M |
2013 Q2
11 quarters
|
|
13
Novartis
NVS
$286B
| $1.52B | 1.57% |
23,367,766
+190,557
| +0.8% | +$13M |
2013 Q2
11 quarters
|
|
14
Alibaba
BABA
$276B
| $1.24B | 1.28% |
15,674,905
+2,133,100
| +16% | +$150M |
2014 Q3
6 quarters
|
|
|
15
JPMorgan Chase
JPM
$891B
| $1.22B | 1.26% |
20,518,581
+6,218,550
| +43% | +$363M |
2015 Q1
4 quarters
|
|
16
Sony
SONY
$144B
| $1.19B | 1.23% |
231,152,750
+7,143,500
| +3% | +$32.8M |
2013 Q2
11 quarters
|
|
17
Carnival Corporation Ltd
CCL
$35.6B
| $1.19B | 1.23% |
22,515,830
+100,400
| +0.4% | +$4.86M |
2013 Q2
11 quarters
|
|
18
NetApp
NTAP
$42.2B
| $1.19B | 1.23% |
43,514,951
+1,562,403
| +4% | +$37.8M |
2013 Q2
11 quarters
|
|
19
United Airlines
UAL
$32.9B
| $1.17B | 1.21% |
19,534,025
+68,025
| +0.3% | +$3.61M |
2013 Q2
11 quarters
|
|
20
Medtronic
MDT
$122B
| $1.14B | 1.18% |
15,196,981
+9,330
| +0.1% | +$703K |
2013 Q2
11 quarters
|
|
|
21
American Airlines Group
AAL
$8.13B
| $1.13B | 1.17% |
27,548,576
+7,692,799
| +39% | +$310M |
2013 Q4
9 quarters
|
|
22
NVIDIA
NVDA
$5.25T
| $1.04B | 1.08% |
1,168,434,000
+5,727,000
| +0.5% | +$4.37M |
2013 Q2
11 quarters
|
|
23
Intel
INTC
$504B
| $1.03B | 1.06% |
31,713,985
+1,808,825
| +6% | +$55.5M |
2013 Q2
11 quarters
|
|
|
MON
24
DELISTED
Monsanto Co
MON
| $1.01B | 1.05% |
11,498,797
-131,600
| -1% | -$11.9M |
2013 Q2
11 quarters
|
|
25
Marsh
MRSH
$89B
| $998M | 1.04% |
16,419,476
-610,775
| -4% | -$34.2M |
2013 Q2
11 quarters
|
|
Similar funds
Primecap Management's Q1 2016 Portfolio in Review
As of Q1 2016, Primecap Management held 280 positions worth $96.4B, down 1.4% from $97.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management's Q1 2016 filing shows 10 new, 138 increased, 66 reduced and 10 closed positions. Its largest new stake was Northern Trust: 1,775,400 shares worth $116M. The largest sale was Johnson & Johnson, an estimated $779M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2016 buy was Northern Trust: 1,775,400 shares worth $116M.
- Primecap Management added most to AstraZeneca in Q1 2016, an estimated $363M increase.
- Primecap Management's biggest Q1 2016 reduction was Johnson & Johnson, cutting an estimated $779M.
- Primecap Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $394M.
- Primecap Management's ten largest holdings make up 34% of its $96.4B portfolio in Q1 2016.
- Primecap Management opened 10 new positions and closed 10 in Q1 2016.
- Primecap Management's portfolio value fell 1.4% quarter-over-quarter to $96.4B.
Based on Primecap Management's 13F filing for Q1 2016, filed 12 May 2016.